FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded access
Reported bySTAT News ↗·Sourced by Goodlede
The Federal Trade Commission settled a lawsuit against CVS Caremark for artificially inflating insulin prices and restricting access; the agency estimates the deal will save Americans up to $8.5 billion in out-of-pocket costs over 10 years plus unlock up to $4.5 billion in additional pharmacy counter rebates.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at STAT News
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede